Safety and efficacy of secukinumab in patients with giant cell arteritis (TitAIN): a randomised, double-blind, placebo-controlled, phase 2 trial
Year: 2023
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Lancet Rheumatology
Authors: Nils Venhoff, Wolfgang A Schmidt, Raoul Bergner, Jürgen Rech, Leonore Unger, Hans-Peter Tony, Stephanie Finzel, Ioana Andreica, David M Kofler, Stefan M Weiner, Peter Lamprecht, Hendrik Schulze-Koops, Christine App, Effie Pournara, Meryl H Mendelson, Christian Sieder, Meron Maricos, Jens Thiel
Institutions: University of Freiburg, University Medical Center Freiburg, Immanuel Krankenhaus, Klinikum Ludwigshafen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsklinikum Erlangen, Städtisches Klinikum Dresden, University of Würzburg, Rheumazentrum Ruhrgebiet, Ruhr University Bochum, University of Cologne, University Hospital Cologne, Johannes Gutenberg University Mainz, Krankenhaus der Barmherzigen Brüder Trier, University of Lübeck, Ludwig-Maximilians-Universität München, Novartis (Germany), Novartis (Switzerland), Medical University of Graz
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Novartis
OpenAlex ID: W4377263836